Delivery Order SPE2DB24D9222-SPE2DB25FAZKH
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on July 24, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, valued at $50,212.60, is set to be completed by August 14, 2025, with performance taking place at the company's Park Ridge location. The award carries no set-aside designation, reflecting the contractor's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of EXPAREL 133 mg/10 mL vials. The contract is valued at $6,092.20 with a firm fixed-price structure and an ultimate completion date of September 23, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an unrestricted basis....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, by the Defense Logistics Agency (DLA) for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $7,531.89 with an ultimate completion date of September 2, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $25,106.30 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract carries an ultimate completion date of September 5, 2025, and involves no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial role...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $30,127.56 by the Defense Logistics Agency (DLA) on August 18, 2025. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials, a long-acting local anesthetic commonly used in surgical and post-operative pain management. This firm fixed-price delivery order, with an ultimate completion date of September 9,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 24, 2025, for EXPAREL 133 mg/10 mL vials. The contract is valued at $1,707.02 and is classified as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. The award carries no set-aside designation, and the place of performance is located in Park Ridge, Illinois. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 by the Defense Logistics Agency on July 25, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $37,659.45 for the supply of EXPAREL 266 mg/20 mL vials. The award, made on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 for EXPAREL 1.3% 20ML (10 units) by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, with the place of performance in Park Ridge, Illinois and an ultimate completion date of September 3, 2025. This award falls under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,021.26 for EXPAREL 1.3% 20ML (10 units) on August 18, 2025. This firm fixed-price delivery order was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The awardee will perform this delivery at its Park Ridge, Illinois location, with an ultimate completion date of August 18, 2025....
- SPE2DB24D9222Indefinite Delivery Contract
- SPE2DB24D9222-SPE2DB25FAZKHDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This firm fixed-price delivery order carries a ceiling value of $37.4K and represents a task order under the company's larger Indefinite Delivery Contract with DLA valued at $500M through November 2026. The contract requires ultimate completion by September 24, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois. No set-aside designation was used for this award. This delivery order exemplifies DMS Pharmaceutical Group's critical role in supplying specialty pharmaceutical products to Department of Defense healthcare facilities. EXPAREL, a long-acting local anesthetic, supports surgical and pain management applications across military medical centers. The award continues the contractor's established pattern of leveraging its small business status to compete effectively in federal pharmaceutical procurement while maintaining a robust portfolio of branded and generic prescription drugs, biologics, and medical consumables distributed to military health facilities nationwide through the DLA supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.4k | 9/3/25 |